Expectations, Ballyhoo and Stem Cell Research
Two seemingly unrelated biotech stories popped up this morning on the news. One involved an international stem cell research brouhaha. The other involved what could amount to a nearly $2 billion biotech deal for a California firm.
What brings them together is the diaphanous nature of some of the work in these much ballyhooed fields. But first, let’s l…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.